LUND, Sweden, March 12, 2024 /PRNewswire/ — Immunovia (IMMNOV: Nasdaq) (IMMNOV: Stockholm), the diagnostics company with the mission to increase pancreatic cancer survival rates through early detection, updates its financial calendar for 2024. Annual Report to be published April 25, 2024…